Navigation Links
Genomic Health Announces Third Quarter 2008 Financial Results and Business Progress
Date:11/5/2008

- Product Revenue Increased 78 Percent Compared with 2007 -

- Net Loss Narrows -

- Quantitative HER2 Scores Now Included in All Oncotype DX Reports -

- Conference Call Today at 4:30 p.m. ET -

REDWOOD CITY, Calif., Nov. 5 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended September 30, 2008.

Total revenue increased to $28.1 million in the third quarter of 2008 compared with $15.9 million in the third quarter of 2007. Product revenue from the Oncotype DX(R) breast cancer assay was $28.1 million in the third quarter of 2008, an increase of 78 percent, compared with $15.8 million in the third quarter of 2007.

Net loss decreased to $3.0 million in the third quarter of 2008, compared with $7.3 million in the third quarter of 2007. Basic and diluted net loss per share was $0.11 in the third quarter of 2008, compared with a net loss per share of $0.26 in the third quarter of 2007.

Cash and cash equivalents and short-term investments at September 30, 2008 were $54.4 million compared with $60.6 million at June 30, 2008, and $68.4 million at December 31, 2007.

"We believe personalized medicine has the power to improve the quality of care while reducing costs, which is especially important during a time of soaring health care expenses and economic uncertainty," said Randy Scott, Ph.D., Chairman and Chief Executive Officer of Genomic Health. "This quarter, we again increased the value of Oncotype DX by the inclusion of quantitative HER2 scores, while continuing to invest in our commercial organization here and abroad. We believe the growing use of our Oncotype DX breast ca
'/>"/>

SOURCE Genomic Health, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Transgenomic, Inc. Reports Second Quarter 2007 Results
2. Rosetta Genomics Announces Annual General Meeting of Shareholders to be Held on September 24, 2007
3. GeneNews Chief Scientist Dr. C.C. Liew co-editor of new genomics reference book
4. CODA Genomics Announces Issuance of Optimized Synthetic Gene Production Patent
5. Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases
6. WallSt.net (www.wallst.net) Announces Upcoming Interview With CEO of DNAPrint Genomics
7. NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA-Based Diagnostic Test for Melanoma
8. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference
9. Rosetta Genomics to Webcast Presentation at Maxim Group Growth Conference
10. BioNanoatrix and Complete Genomics Receive $8.8 Million NIST-ATP Award to Develop Sequencing Platform for $100 Genome
11. BioNanomatrix and Complete Genomics Receive $8.8 Million NIST-ATP Award to Develop Sequencing Platform for $100 Genome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014 TaiGen Biotechnology Company, Limited ... agreement with R-Pharm, a leading Russian pharmaceutical company, to ... Russian Federation , Turkey ... States (CIS). Nemonoxacin is a novel antibiotic for the treatment ...
(Date:1/14/2014)... Jan. 14, 2014  3D Communications, a leading provider of strategic communications ... and media events in the United States ... Virginia Cox , JD, is returning to the firm,s ... re-joins 3D after more than two years of service as ...
(Date:1/14/2014)... and BETHESDA, Md. , Jan. 14, ... with two institutes from the National Institutes of Health ... bringing safer, more effective treatments to patients on a ... for Advancing Translational Sciences (NCATS) and the National Eye ...
(Date:1/14/2014)... Rockville, MD (PRWEB) January 14, 2014 ... dedicated to developing innovative information technology solutions for ... other health care stakeholders, announced today the signing ... the US Food and Drug Administration (FDA). ...
Breaking Biology Technology:TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4Former FDA Associate Commissioner Returns To 3D Communications 2Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2
... , ... (AAA) are so deadly, they kill 13,000 Americans every year. Minimally invasively emergency repair of ... data. The latest research on AAA is being presented at the 22nd annual International ... ...
... nitride nanotubes (BNNTs) are the divas of the nanoworld. ... temperamental compared to their carbon-based cousins. On the ... over 1,100 degrees Celsius, says Yoke Khin Yap, an ... nanotubes would burn like charcoal in a barbecue at ...
... , FT. LAUDERDALE, Fla. , Jan. 15 ... Green Hedge Fund to provide further investment for the company,s growth ... new level" is how CEO Chris Hamilton views this ... As controlling and ultimately reducing Carbon Emissions feature so highly on ...
Cached Biology Technology:Minimally Invasive Repair of Ruptured Aortic Aneurysm Could Save More Lives than Surgery 2Minimally Invasive Repair of Ruptured Aortic Aneurysm Could Save More Lives than Surgery 3Minimally Invasive Repair of Ruptured Aortic Aneurysm Could Save More Lives than Surgery 4Minimally Invasive Repair of Ruptured Aortic Aneurysm Could Save More Lives than Surgery 5Harnessing the divas of the nanoworld 2InfoSpi to Create $500m Green Hedge Fund Focusing on the Carbon Credit Market 2
(Date:4/24/2014)... - Purdue and West Virginia University researchers are the ... providing a bird,s-eye view of eagle features that could ... study calls into question long-held assumptions about golden eagle ... sensitive to ultraviolet light as previously thought. The genome ... sense of smell than researchers realized. , Additionally, ...
(Date:4/24/2014)... been published in the Scientific Reports journal. , ... (a joint centre of CSIC and Pompeu Fabra University-UPF), explains: ... and we saw that it did not match with the ... sequence the complete genome and to make a functional interpretation ... to Louis XVI". , The functional genome analysis was ...
(Date:4/24/2014)... study representing the largest study of animal intelligence to-date finds ... self-control. , Published this week in the journal Proceedings ... part of a long history of research aimed at understanding ... do things like make and use tools, read social cues, ... Until now, most studies of animal intelligence have focused on ...
Breaking Biology News(10 mins):Genome yields insights into golden eagle vision, smell 2The blood preserved in the pumpkin did not belong to Louis XVI 2Animals with bigger brains, broader diets have better self control 2Animals with bigger brains, broader diets have better self control 3
... This press release is available in German . ... a UFZ German scientist found that the worldwide ... pollinators, bees mainly, was 153 billion in 2005 for ... amounted to 9.5% of the total value of the ...
... been referred to as an "essential toxin" due to ... between the nutritious requirement and toxic effects upon exposure. ... have lead to the characterization of selenium as a ... narrow threshold concentration in ecosystems through anthropogenic activities. Ironically, ...
... Journalists are invited to attend the 20th EORTCNCIAACR ... Geneva, Switzerland [Geneva Palexpo, Geneva] from Tuesday 21 ... is the deadline for booking accommodation via the ... this symposium, organised jointly by the European Organisation ...
Cached Biology News:Economic value of insect pollination worldwide estimated at 153 billion euros 2Economic value of insect pollination worldwide estimated at 153 billion euros 3Biological selenium removal: The solution to pollution? 2Media invitation: 20th EORTC-NCI-ACR Symposium on Molecular Targets and Cancer Therapeutics 2